CoSyne Therapeutics
Upscaling science with polymathic AI
- Headquarters
- London
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- cosyne.com
- Total Funding
- $8.8M
- Last Round
- $7.8M SeedMay 2022
About
Vertically integrated AI drug discovery company using polymathic AI foundation models for biology and chemistry. Aims to bring speed to precision medicine by working backwards from the clinic to develop innovative computational and experimental solutions.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account